Vulvodynia

Journal of Sexual Medicine

Volumn 5, Issue 1, 2008, Pages 5-15

  Goldstein, Andrew T ^a,b   Burrows, Lara ^a,c  

^a The Centers for Vulvovaginal Disorders   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Etiology; Sexual pain; Vulvodynia

Indexed keywords

AMITRIPTYLINE; ANESTHETIC AGENT; ANTIDEPRESSANT AGENT; ANTIFUNGAL AGENT; ATROPINE; BACLOFEN; BENZOCAINE; BOTULINUM TOXIN A; CAPSAICIN; CARBAMAZEPINE; CORTICOSTEROID; DESIPRAMINE; DIPHENHYDRAMINE; DOXEPIN; EMLA; EMOLLIENT AGENT; ESTRADIOL; GABAPENTIN; GLYCERYL TRINITRATE; LIDOCAINE; LMX 4; LMX 5; NORTRIPTYLINE; PETROLATUM; SEROTONIN UPTAKE INHIBITOR; TESTOSTERONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VAGISIL; ZINC OXIDE;

ARTICLE; BALANCE DISORDER; BEDTIME DOSAGE; CLINICAL TRIAL; COGNITIVE DEFECT; CONSTIPATION; COPING BEHAVIOR; DIZZINESS; DROWSINESS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG SAFETY; DYSPAREUNIA; FEEDBACK SYSTEM; FEMALE SEXUAL DYSFUNCTION; GAIT DISORDER; GASTROINTESTINAL SYMPTOM; GENITAL PRURITUS; GRANULATION TISSUE; GYNECOLOGIC SURGERY; HEREDITY; HUMAN; IRRITANT DERMATITIS; LOW DRUG DOSE; MEDICAL EDUCATION; MENTAL DISEASE; NEURALGIA; NONHUMAN; ORGASM DISORDER; PATHOGENESIS; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT MONITORING; PERIPHERAL EDEMA; PERSONAL HYGIENE; PHYSICAL EXAMINATION; PHYSIOTHERAPY; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; PSYCHOSEXUAL DISORDER; RECOMMENDED DRUG DOSE; RISK ASSESSMENT; RISK FACTOR; SEXUAL BEHAVIOR; SKIN ALLERGY; SKIN ATROPHY; SOMNOLENCE; VULVA VESTIBULECTOMY; VULVAR VESTIBULITIS; VULVODYNIA; VULVOVAGINITIS; WOUND INFECTION; XEROSTOMIA;

EID: 37549016341     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2007.00679.x     Document Type: Article

References (48)

1. Moyal-Barracco M, Lynch PJ. 2003 ISSVD terminology and classification of vulvodynia: A historical perspective. J Reprod Med 2004;49:772-7.
2. Goldstein AT, Marinoff SC, Haefner HK. Vulvodynia: Strategies for treatment. Clin Obstet Gynecol 2005;48:769-85.
3. Eva LJ, Rolfe KJ, MacLean AB, Reid WM, Fong AC, Crow J, Perrett CW. Is localized, provoked vulvodynia an inflammatory condition? J Reprod Med 2007;52:379-84.
4. Jones KD, Lehr ST. Vulvodynia: Diagnostic techniques and treatment modalities. Nurse Pract 1994;19:34, 37-46.
5. Denbow ML, Byrne MA. Prevalence, causes and outcome of vulval pain in a genitourinary medicine clinic population. Int J STD AIDS 1998;9:88-91.
6. Reed BD, Crawford S, Couper M, Cave C, Haefner HK. Pain at the vulvar vestibule: A web-based survey. J Low Genit Tract Dis 2004;8:48-57.
7. Harlow BL, Stewart EG. A population-based assessment of chronic unexplained vulvar pain: Have we underestimated the prevalence of vulvodynia? J Am Med Womens Assoc 2003;58:82-8.
8. Burrows LJ KD, Pukall CF, Goldstein AT. Umbilical hypersensitivity in women with primary vestibulodynia. J Reprod Med 2007;(in press).
9. Witkin SS, Gerber S, Ledger WJ. Differential characterization of women with vulvar vestibulitis syndrome. Am J Obstet Gynecol 2002;187:589-94.
10. Witkin SS, Gerber S, Ledger WJ. Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis 2002;34:204-9.
11. Babula O, Danielsson I, Sjoberg I, Ledger WJ, Witkin SS. Altered distribution of mannose-binding lectin alleles at exon I codon 54 in women with vulvar vestibulitis syndrome. Am J Obstet Gynecol 2004;191:762-6.
12. Bohm-Starke N, Johannesson U, Hilliges M, Rylander E, Torebjork E. Decreased mechanical pain threshold in the vestibular mucosa of women using oral contraceptives: A contributing factor in vulvar vestibulitis? J Reprod Med 2004;49:888-92.
13. Bohm-Starke N, Hilliges M, Falconer C, Rylander E. Increased intraepithelial innervation in women with vulvar vestibulitis syndrome. Gynecol Obstet Invest 1998;46:256-60.
14. Bornstein J, Goldschmid N, Sabo E. Hyperinnervation and mast cell activation may be used as histopathologic diagnostic criteria for vulvar vestibulitis. Gynecol Obstet Invest 2004;58:171-8.
15. Westrom LV, Willen R. Vestibular nerve fiber proliferation in vulvar vestibulitis syndrome. Obstet Gynecol 1998;91:572-6.
16. Pukall CF, Binik YM, Khalife S, Amsel R, Abbott FV. Vestibular tactile and pain thresholds in women with vulvar vestibulitis syndrome. Pain 2002;96:163-75.
17. Babula O, Bongiovanni AM, Ledger WJ, Witkin SS. Immunoglobulin E antibodies to seminal fluid in women with vulvar vestibulitis syndrome: Relation to onset and timing of symptoms. Am J Obstet Gynecol 2004;190:663-7.
18. Glazer HI, Jantos M, Hartmann EH, Swencionis C. Electromyographic comparisons of the pelvic floor in women with dysesthetic vulvodynia and asymptomatic women. J Reprod Med 1998;43:959-62.
19. Shafik A. Pudendal canal syndrome as a cause of vulvodynia and its treatment by pudendal nerve decompression. Eur J Obstet Gynecol Reprod Biol 1998;80:215-20.
20. Gaunt G, Good AE, McGovern RM, Stanhope CR, Gostout BS. Human papillomavirus in vulvar vestibulitis syndrome. J Reprod Med 2007;52:485-9.
21. Orlandi A, Francesconi A, Angeloni C, Palmieri G, Fulvia G, Ciotti M, Criscuolo A, Sesti F, Spagnoli LG. Prevalence and genotyping of human papillomavirus infection in women with vulvodynia. Acta Obstet Gynecol Scand 2007;86:1003-10.
22. Greenstein A, Militscher I, Chen J, Matzkin H, Lessing JB, Abramov L. Hyperoxaluria in women with vulvar vestibulitis syndrome. J Reprod Med 2006;51:500-2.
23. Poole S, Ravenhill G, Munday PE. A pilot study of the use of a low oxalate diet in the treatment of vulval vestibulitis. J Obstet Gynaecol 1999;19:271-2.
24. Ferris DG, Nyirjesy P, Sobel JD, Soper D, Pavletic A, Litaker MS. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol 2002;99:419-25.
25. Edwards L. New concepts in vulvodynia. Am J Obstet Gynecol 2003;189(3suppl):S24-30.
26. Pukall CF, Strigo IA, Binik YM, Amsel R, Khalife S, Bushnell MC. Neural correlates of painful genital touch in women with vulvar vestibulitis syndrome. Pain 2005;115:118-27.
27. Gordon AS, Panahian-Jand M, McComb F, Melegari C, Sharp S. Characteristics of women with vulvar pain disorders: Responses to a web-based survey. J Sex Marital Ther 2003;29(1suppl):45-58.
28. Zolnoun DA, Hartmann KE, Steege JF. Overnight 5% lidocaine ointment for treatment of vulvar vestibulitis. Obstet Gynecol 2003;102:84-7.
29. Davis GLT, Richard J. Oral vestibulitis vulvar syndrome. J Reprod Med 2007;52:116-7.
30. Steinberg AC, Oyama IA, Rejba AE, Kellogg-Spadt S, Whitmore KE. Capsaicin for the treatment of vulvar vestibulitis. Am J Obstet Gynecol 2005;192:1549-53.
31. Walsh KE, Berman JR, Berman LA, Vierregger K. Safety and efficacy of topical nitroglycerin for treatment of vulvar pain in women with vulvodynia: A pilot study. J Gend Specif Med 2002;5:21-7.
32. Munday PE. Response to treatment in dysaesthetic vulvodynia. J Obstet Gynaecol 2001;21:610-3.
33. Haefner HK, Collins ME, Davis GD, Edwards L, Foster DC, Hartmann ED, Kaufman RH, Lynch PJ, Margesson LJ, Moyal-Barracco M, Piper CK, Reed BD, Stewart EG, Wilkinson EJ. The vulvodynia guideline. J Low Genit Tract Dis 2005;9:40-51.
34. Glazer HI, Rodke G, Swencionis C, Hertz R, Young AW. Treatment of vulvar vestibulitis syndrome with electromyographic biofeedback of pelvic floor musculature. J Reprod Med 1995;40:283-90.
35. Rosenbaum TY. Physiotherapy treatment of sexual pain disorders. J Sex Marital Ther 2005;31:329-40.
36. Hartmann D, Nelson CA. The perceived effectiveness of physical therapy treatment on women complaining of chronic vulvar pain and diagnosed with either vulvar vestibulitis syndrome or dysestheic vulvodynia. J Sect Women's Health APTA 2001;25:13-8.
37. Bergeron S, Brown C, Lord MJ, Oala M, Binik YM, Khalife S. Physical therapy for vulvar vestibulitis syndrome: A retrospective study. J Sex Marital Ther 2002;28:183-92.
38. Murina F, Tassan P, Roberti P, Bianco V. Treatment of vulvar vestibulitis with submucous infiltrations of methylprednisolone and lidocaine. An alternative approach. J Reprod Med 2001;46:713-6.
39. Yoon H, Chung WS, Shim BS. Botulinum toxin A for the management of vulvodynia. Int J Impot Res 2007;19:84-7.
40. Woodruff JD GR, Poliakoff S. Treatment of dyspareunia and vaginal outlet distortions by perineoplasty. Obstet Gynecol 1981;57:750-4.
41. Goldstein AT, Klingman D, Christopher K, Johnson C, Marinoff SC. Surgical treatment of vulvar vestibulitis syndrome: Outcome assessment derived from a postoperative questionnaire. J Sex Med 2006;3:923-31.
42. Goldstein A. Surgical techniques: Surgery for vulvar vestibulitis syndrome. J Sex Med 2006;3:559-62.
43. Dalton VK, Haefner HK, Reed BD, Senapati S, Cook A. Victimization in patients with vulvar dysesthesia/vestibulodynia. Is there an increased prevalence? J Repro Med 2002;47:829-34.
44. Danielsson I, Sjoberg I, Wikman M. Vulvar vestibulitis: Medical, psychosexual and psychosocial aspects, a case-control study. Acta Obstet Gynecol Scand 2000;79:872-8.
45. Brotto LA, Basson R, Gehring D. Psychological profiles among women with vulvar vestibulitis syndrome: A chart review. J Psychosom Obstet Gynaecol 2003;24:195-203.
46. Bergeron S, Binik YM, Khalife S, Padigas K, Glazer HI, Meana M, Amsel R. A randomized comparison of group cognitive-behavioral therapy, surface electromyographic biofeedback, and vestibulectomy in the treatment of dyspareunia resulting from vulvar vestibulitis. Pain 2001;91:297-306.
47. Pukall C, Kandyba K, Amsel R, Khalife S, Binik Y. Effectiveness of hypnosis for the treatment of vulvar vestibulitis syndrome: A preliminary investigation. J Sex Med 2007;4:417-25.
48. Bergeron S, Binik YM, Khalife S. In favor of an integrated pain-relief treatment approach for vulvar vestibulitis syndrome. J Psychosom Obstet Gynaecol 2002;23:7-9.